Ertapenem

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Ertapenem
Ertapenem Formula V.1.svg
Clinical data
Trade names Invanz
AHFS/Drugs.com Monograph
License data
Pregnancy
category
  • AU: B3
  • US: B (No risk in non-human studies)
Routes of
administration
Intramuscular, intravenous
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability 90% (intramuscular)
Protein binding Inversely proportional to concentration; 85 to 95%
Metabolism Minor hydrolysis of beta-lactam ring, CYP not involved
Elimination half-life 4 hours
Excretion Renal (80%) and fecal (10%)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
Formula C22H25N3O7S
Molar mass 475.516 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz.[1]

References[edit]

  1. ^ Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (November 2011). "Carbapenems: past, present, and future". Antimicrob. Agents Chemother. 55 (11): 4943–60. doi:10.1128/AAC.00296-11. PMC 3195018Freely accessible. PMID 21859938.